Intuitive Surgical Stock Hits 52-Week Low on Institutional Selling, Safety Worries

Overview

• The shares touched $427.79 intraday and closed near $423.22, a roughly 6% drop that extends the year-to-date decline to more than 20%.
• Large institutions have been trimming positions in recent weeks, creating steady selling pressure on the stock.
• Ongoing FDA safety alerts and product recalls tied to the da Vinci surgical robots continue to weigh on investor confidence.
• The slide follows a strong first quarter that beat forecasts, with revenue of $2.77 billion up 23% and earnings per share of $2.50 up 38%.
• Analysts remain positive, with about 15 recent upward estimate revisions and firms including Bernstein, RBC, Piper Sandler, and Barclays keeping Outperform or Overweight ratings with price targets.